Oragenics, Inc.
OGEN
$0.50
-$0.01-2.27%
AMEX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | 1.18M | 645.50K | 670.50K | 930.90K | 449.70K |
| Gross Profit | -1.18M | -645.50K | -670.50K | -930.90K | -449.70K |
| SG&A Expenses | 1.42M | 1.61M | 1.83M | 2.19M | 1.26M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.59M | 2.26M | 2.50M | 3.12M | 1.71M |
| Operating Income | -2.59M | -2.26M | -2.50M | -3.12M | -1.71M |
| Income Before Tax | -2.58M | -2.22M | -2.42M | -3.07M | -2.27M |
| Income Tax Expenses | -46.40K | -22.60K | -136.90K | -- | -- |
| Earnings from Continuing Operations | -2.53M | -2.20M | -2.29M | -3.07M | -2.27M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.53M | -2.20M | -2.29M | -3.07M | -2.27M |
| EBIT | -2.59M | -2.26M | -2.50M | -3.12M | -1.71M |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -0.57 | -0.51 | -0.54 | -1.96 | -3.10 |
| Normalized Basic EPS | -0.36 | -0.32 | -0.36 | -1.23 | -1.94 |
| EPS Diluted | -0.57 | -0.51 | -0.54 | -1.96 | -3.10 |
| Normalized Diluted EPS | -0.36 | -0.32 | -0.36 | -1.23 | -1.94 |
| Average Basic Shares Outstanding | 4.43M | 4.30M | 4.23M | 1.56M | 731.80K |
| Average Diluted Shares Outstanding | 4.43M | 4.30M | 4.23M | 1.56M | 731.80K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |